The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Shikh E.V.

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Lazareva N.B.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia

Khalaidzheva K.N.

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Changes for the Better

Authors:

Shikh E.V., Lazareva N.B., Khalaidzheva K.N.

More about the authors

Journal: Non Nocere. New Therapeutic Journal. 2026;(3): 32‑41

Read: 162 times

Contact the author
Table of contents

To cite this article:

Shikh EV, Lazareva NB, Khalaidzheva KN. Changes for the Better. Non Nocere. New Therapeutic Journal. 2026;(3):32‑41. (In Russ.)

МСФ на ЯМ
Использование инфографики авторами научных работ
Abstract:

Current approaches to drug therapy for vulvovaginal infections.

Authors:

Shikh E.V.

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Lazareva N.B.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia

Khalaidzheva K.N.

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Close metadata

References:

  1. Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021 Jul 23;70(4):1-187.  https://doi.org/10.15585/mmwr.rr7004a1
  2. Inflammatory diseases of the cervix, vagina and vulva: rubricator of clinical recommendations / Ministry of Health of the Russian Federation. - Electron. Dan. – 2025. – ID: 989_1 (date of access: 01/24/2026). https://cr.minzdrav.gov.ru/view-cr/989_1
  3. Sobel JD, Subramanian C, Foxman B, Fairfax M, Gygax SE. Mixed vaginitis-more than coinfection and with therapeutic implications. Curr Infect Dis Rep. 2013 Apr;15(2):104-108.  https://doi.org/10.1007/s11908-013-0325-5
  4. Torshin I.Yu., Apolikhina I.A., Baranov I.I., Tapilskaya N.I., Savicheva A.M., Gromova O.A. The efficacy and safety of a combination of tinidazole and thioconazole in the treatment of vaginal infections. Akusherstvo i Ginekologiya. 2020; 4: 214-222. (In Russ.) https://doi.org/10.18565/aig.2020.4.214-222
  5. Broache M, Cammarata CL, Stonebraker E, Eckert K, Van Der Pol B, Taylor SN. Performance of a Vaginal Panel Assay Compared With the Clinical Diagnosis of Vaginitis. Obstet Gynecol. 2021 Dec 1;138(6):853-859.  https://doi.org/10.1097/AOG.0000000000004592
  6. Paladine HL, Desai UA. Vaginitis: Diagnosis and Treatment. Am Fam Physician. 2018 Mar 1;97(5):321-329. 
  7. Tuddenham S, Hamill MM, Ghanem KG. Diagnosis and Treatment of Sexually Transmitted Infections: A Review. JAMA. 2022 Jan 11;327(2):161-172.  https://doi.org/10.1001/jama.2021.23487
  8. Muzny CA, Cerca N, Elnaggar JH, Taylor CM, Sobel JD, Van Der Pol B. State of the Art for Diagnosis of Bacterial Vaginosis. J Clin Microbiol. 2023 Aug 23;61(8):e0083722. https://doi.org/10.1128/jcm.00837-22
  9. Voropaeva N.M., Belkova N.L., Nemchenko J.M., Grigorova E.V., Danusevich I.N. Microorganisms associated with bacterial vaginosis: diversity and clinical and diagnostic significance. Acta Biomedica Scientifica. 2021;6(3):17-30. (In Russ.) https://doi.org/10.29413/ABS.2021-6.3.2
  10. Shikh E.V., Lazareva N.B., Ponomarenko T.M. Short courses of antimicrobial therapy for bacterial vaginosis: the possibilities of modern pharmacology: A review. Gynecology. 2022;24(4):271-276.  https://doi.org/10.26442/20795696.2022.4.201826
  11. Hussain A, Ahsan F. The vagina as a route for systemic drug delivery. J Control Release. 2005 Mar 21;103(2):301-313.  https://doi.org/10.1016/j.jconrel.2004.11.034
  12. Ferguson LM, Rohan LC. The importance of the vaginal delivery route for antiretrovirals in HIV prevention. Ther Deliv. 2011 Dec;2(12):1535-1550. https://doi.org/10.4155/tde.11.126
  13. De Araújo Pereira RR, Bruschi ML. Vaginal mucoadhesive drug delivery systems. Drug Dev Ind Pharm. 2012 Jun;38(6):643-652.  https://doi.org/10.3109/03639045.2011.623355
  14. Shikh E.V., Lazareva N.B., Shikh N.V. Comparative clinical and pharmacological characteristics of antimicrobial drugs for the treatment of vulvovaginal infections. Issues of gynecology, obstetrics and perinatology. 2025;24(6):149-158.  https://doi.org/10.20953/1726-1678-2025-6-149-158
  15. LS GEOTAR: reference book of medicines / Publishing house “GEOTAR-Media”. – Electron. Dan. – M., 2026 (date of access: 01/24/2026). https://www.lsgeotar.ru/
  16. Slimings C, Riley TV. Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. J Antimicrob Chemother. 2014 Apr;69(4):881-891.  https://doi.org/10.1093/jac/dkt477
  17. Gorbunova EA, Apolikhina IA. On the diagnosis and treatment of refractory and recurrent vaginosis and vaginitis in the practice of a gynecologist. Meditsinskiy sovet = Medical Council. 2024;(4):75-82. (In Russ.) https://doi.org/10.21518/ms2024-165
  18. Mendling W, Weissenbacher ER, Gerber S, Prasauskas V, Grob P. Use of locally delivered dequalinium chloride in the treatment of vaginal infections: a review. Arch Gynecol Obstet. 2016 Mar;293(3):469-484.  https://doi.org/10.1007/s00404-015-3914-8
  19. Sherrard J, Wilson J, Donders G, Mendling W, Jensen JS. 2023 update to 2018 European (IUSTI/WHO) guideline on the management of vaginal discharge. Int J STD AIDS. 2023 Sep;34(10):745.  https://doi.org/10.1177/09564624231179277
  20. Carter KA, Tuddenham S, Brotman RM. Dequalinium Chloride – An Emerging Option in the Sparse Landscape of Bacterial Vaginosis Therapies. JAMA Netw Open. 2024 May 1;7(5):e248606. https://doi.org/10.1001/jamanetworkopen.2024.8606
  21. Kira E.F., Gamirova E.V., Gaitukieva R.A., Belyakina I.V. Results of a randomized trial of the effectiveness and safety of chlorhexidine and metronidazole in the treatment of bacterial vaginosis. Obstetrics and gynecology. 2010;6:123-129. 
  22. Apolikhina I.A., Efendieva Z.N. Modern trends in the treatment of bacterial vaginosis. Obstetrics and gynecology. 2019;12:193-196.  https://doi.org/10.18565/aig.2019.12:193-196
  23. Hijona JJ, Carballo AL, Sánchez MS, Dyachkova N, Expósito JF, Alcázar JL. Vaginal antiseptics reduce the risk of perinatal infection with group B streptococci. J Matern Fetal Neonatal Med. 2019 Aug;32(16):2741-2745. https://doi.org/10.1080/14767058.2018.1449196
  24. Eckel F, Farr A, Deinsberger J, Kernmayer-Farr K, Foessleitner P. Dequalinium Chloride for the Treatment of Vulvovaginal Infections: A Systematic Review and Meta-Analysis. J Low Genit Tract Dis. 2024 Jan 1;28(1):76-83.  https://doi.org/10.1097/LGT.0000000000000790
  25. Raba G, Durkech A, Malík T, et al. Efficacy of Dequalinium Chloride vs Metronidazole for the Treatment of Bacterial Vaginosis: A Randomized Clinical Trial. JAMA Netw Open. 2024 May 1;7(5):e248661. https://doi.org/10.1001/jamanetworkopen.2024.8661
  26. Bradshaw CS, Morton AN, Hocking J, et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis. 2006 Jun 1;193(11):1478-1486. https://doi.org/10.1086/503780
  27. Swidsinski A, Mendling W, Loening-Baucke V, Swidsinski S, Dörffel Y, Scholze J, Lochs H, Verstraelen H. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am J Obstet Gynecol. 2008 Jan;198(1):97.e1-6.  https://doi.org/10.1016/j.ajog.2007.06.039
  28. Khryanin A.A., Knorring G.Y. Modern understanding of bacterial vaginosis. Gynecology. 2021;23(1):37-42.  https://doi.org/10.26442/20795696.2021.1.200680
  29. Swidsinski A, Mendling W, Loening-Baucke V, et al. Adherent biofilms in bacterial vaginosis. Obstet Gynecol. 2005 Nov;106(5 Pt 1):1013-1023. https://doi.org/10.1097/01.AOG.0000183594.45524.d2
  30. Swidsinski A., Verstraelen H, Loening-Baucke V, Swidsinski S, Mendling W, Halwani Z. Presence of a polymicrobial endometrial biofilm in patients with bacterial vaginosis. PLoS One. 2013;8(1):e53997. https://doi.org/10.1371/journal.pone.0053997
  31. Verwijs MC, Agaba SK, Darby AC, van de Wijgert JHHM. Impact of oral metronidazole treatment on the vaginal microbiota and correlates of treatment failure. Am J Obstet Gynecol. 2020 Feb;222(2):157.e1-157.e13.  https://doi.org/10.1016/j.ajog.2019.08.008
  32. Gaspar C, Rolo J, Cerca N, Palmeira-de-Oliveira R, Martinez-de-Oliveira J, Palmeira-de-Oliveira A. Dequalinium Chloride Effectively Disrupts Bacterial Vaginosis (BV) Gardnerella spp. Biofilms. Pathogens. 2021 Feb 25;10(3):261.  https://doi.org/10.3390/pathogens10030261
  33. Zhai Y, Pribis JP, Dooling SW, et al. M. Drugging evolution of antibiotic resistance at a regulatory network hub. Sci Adv. 2023 Jun 23;9(25): eadg0188. https://doi.org/10.1126/sciadv.adg0188
  34. Shikh E.V., Makhova A.A., Kostin R.K. Pharmacotherapy for bacterial vaginosis: antibiotics vs antiseptics. Vopr. ginekol. akus. perinatol. (Gynecology, Obstetrics and Perinatology). 2023; 22(4): 112-120. (In Russ.) https://doi.org/10.20953/1726-1678-2023-4-112-120
  35. Kira E.F., Rastorgueva L.I., Khalturina Yu.V., Pushkina V.V. Vaginal infections. Two-step treatment. Akusherstvo i Ginekologiya. 2020; 4: 201-208  https://doi.org/10.18565/aig.2020.4.201-208
  36. Lopes dos Santos Santiago G, Grob P, Verstraelen H, Waser F, Vaneechoutte M. Susceptibility testing of Atopobium vaginae for dequalinium chloride. BMC Res Notes. 2012 Mar 19;5:151.  https://doi.org/10.1186/1756-0500-5-151
  37. Savicheva A.M., Shalepo K.V., Nazarova V.V., Menukhova Yu.N. A comparative controlled randomized study evaluating the effectiveness of two-stage treatment of bacterial vaginosis. Gynecology. 2015;15(5):12-15. 
  38. Savicheva A.M., Tapilskaya N.I., Krysanova A.A., Budilovskaya O.V., Khusnutdinova T.A., Shalepo K.V. Long-term results of two-stage treatment of bacterial vaginosis using antiseptics and probiotics. Akusherstvo i ginekologiya: novosti, mneniya, obuchenie [Obstetrics and Gynecology: News, Opinions, Training]. 2021;9(4):19-28.  https://doi.org/10.33029/2303-9698-2021-9-4-19-28
  39. Orazov MR, Silant’yeva ES, Radzinskii VE, et al. Risk factors and pathogenetic mechanisms of genitourinary menopausal syndrome. Russian Bulletin of Obstetrician-Gynecologist. 2023;23(4):44-49. (In Russ.) https://doi.org/10.17116/rosakush20232304144
  40. Sinchikhin S.P., Stepanyan L.V., Ikhtiyarova G.A., Mamiev O.B., Seidova A.M. Genitourinary syndrome of menopause: Important aspects of the pathogenesis, diagnosis, and treatment: A review. Gynecology. 2025;27(4):287-293.  https://doi.org/10.26442/20795696.2025.4.203533
  41. Menopause and menopause in women: rubricator of clinical recommendations / Ministry of Health of the Russian Federation. - Electron. Dan. – 2025. – ID: 117_3 (date of access: 01/26/2026). https://cr.minzdrav.gov.ru/view-cr/117_3
  42. Apolikhina IA, Tarnaeva LA. Current trends in the prevention and treatment of genitourinary menopausal syndrome. Meditsinskiy sovet = Medical Council. 2023;(15):111-116. (In Russ.) https://doi.org/10.21518/ms2023-294
  43. Nazarova N.M., Prilepskaya V.N., Mgeryan A.N., Dovletkhanova E.R., Abakarova P.R., Mezhevitinova E.A. Management of patients with vulvovaginal atrophy and cytological abnormalities. Gynecology. 2023;25(3):360-363.  https://doi.org/10.26442/20795696.2023.3.202339
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.